GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
H

Herborium Group HBRM · USD

Consumer Staples · US listing · 🇺🇸 United States

Compare

0.00

0.00%

Close of 5 Nov 2026, in USD

At a glance

Figures in USD, from our data supplier.

FY2025

Revenue

$788,250

FY2016FY2025

Net income

−$154,770

FY2016FY2025

Free cash flow

—

FY2016FY2025

Shareholders' equity

−$4.3m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue$788,250$1.1m$1.1m$1.1m$1.1m$993,500$875,000$816,300$908,600$843,200
Gross profit$496,500$662,000$624,345$702,200$662,000$639,200$510,000$477,500$560,200$530,100
Research and development$150,000$161,000$35,650$30,900——————
Operating income−$238,000−$287,500$28,720−$267,040−$287,500$68,700−$54,000−$86,300$34,900$3,400
Net income−$154,770−$328,770$29,523−$267,040−$328,770$47,100−$76,000−$174,100−$32,200−$54,700
Diluted earnings per share-0.00-0.000.00-0.00-0.000.00-0.00-0.00-0.00-0.00

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets$142,820$157,200$156,300$175,100$170,000$206,500$173,000$229,600$187,600$173,400
Cash and short-term investments$5,125$10,250$10,250$13,500$8,000$13,500$6,000$8,600$3,700$8,400
Total liabilities$4.1m$4.1m$4.5m$4.1m$4.0m$709,700$728,900$709,900$552,000$446,200
Debt$1.1m$1.1m$1.1m$1.1m$1.1m$405,300$329,000$321,600$325,300$407,200
Shareholders' equity−$4.3m−$4.3m−$4.3m−$4.0m−$3.8m−$503,200−$555,400−$479,400−$365,000−$272,800
Shares outstanding10,919m10,919m10,919m9,321m9,630m10,919m10,919m10,919m10,919m10,919m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations——$369,970−$133,290$94,100−$43,400−$71,000−$117,500$79,600$8,800
Capital spending——−$1,850−$1,600−$42,100—————
Free cash flow——$368,120−$134,890$52,000−$43,400−$71,000−$117,500$79,600$8,800

Latest quarters

By quarter end

Aug 2026May 2026Feb 2026Nov 2025Aug 2025May 2025Feb 2025Nov 2024
Revenue$85,000$29,250$269,250$428,550$59,900$69,900$229,900$245,350
Gross profit$40,000$15,250$140,250$283,800$40,900$40,900$130,900$241,960
Operating income−$18,000−$26,750−$31,390−$223,310−$8,900−$18,900$13,110−$323,360
Net income−$18,010−$26,750−$65,010−$130,080−$8,900−$18,900$3,110−$364,630
Diluted earnings per share-0.00-0.00-0.00-0.00-0.00-0.000.00-0.00
Total assets$117,650$75,100$142,820$142,820$150,200$155,200$157,200$157,200
Cash and short-term investments$2,550$3,500$5,125$5,125$7,000$7,000$10,250$10,250
Debt$200,000$401,593$401,593$401,593$401,593$501,592$401,593$401,593
Shareholders' equity−$4.3m−$4.3m−$4.3m−$4.3m−$2.5m−$4.3m−$4.3m−$4.3m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-11.4%-4.5%1.0%
Operating income-3.8%—14.7%
Net income-16.6%—5.9%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin63.0%60.7%61.7%61.4%
Operating margin-28.6%-18.7%-16.0%-11.1%
Net margin-26.3%-17.6%-16.3%-13.9%

Valuation history

At each fiscal year end

FY2025FY2024FY2023
Price to earnings-0.4-0.20.0
Price to sales0.10.1—

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return100%12700%12700%-50%69%450%100%819100%3276700%100%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 1000-to-1 reverse split · 27 Jan 2014

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.